Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Profit After Tax: 2010-2025

Historic Profit After Tax for Niagen Bioscience (NAGE) over the last 14 years, with Sep 2025 value amounting to $4.6 million.

  • Niagen Bioscience's Profit After Tax rose 143.77% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.5 million, marking a year-over-year increase of 1281.55%. This contributed to the annual value of $8.6 million for FY2024, which is 274.16% up from last year.
  • As of Q3 2025, Niagen Bioscience's Profit After Tax stood at $4.6 million, which was up 26.85% from $3.6 million recorded in Q2 2025.
  • Niagen Bioscience's Profit After Tax's 5-year high stood at $7.2 million during Q4 2024, with a 5-year trough of -$8.9 million in Q3 2021.
  • Moreover, its 3-year median value for Profit After Tax was $114,000 (2023), whereas its average is $1.5 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first plummeted by 110.11% in 2021, then spiked by 24,160.00% in 2025.
  • Quarterly analysis of 5 years shows Niagen Bioscience's Profit After Tax stood at -$5.3 million in 2021, then skyrocketed by 73.37% to -$1.4 million in 2022, then surged by 108.04% to $114,000 in 2023, then soared by 6,241.23% to $7.2 million in 2024, then soared by 143.77% to $4.6 million in 2025.
  • Its last three reported values are $4.6 million in Q3 2025, $3.6 million for Q2 2025, and $5.1 million during Q1 2025.